Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1103

Canola protein isolate

Intended Use: Intended for use as a protein source, formulation aid, nutrient supplement, stabilizer and thickener, and texturizer at maximum levels ranging from 5 to 100% in baked goods and baking mixes, non-alcoholic beverages and beverage bases, coffee and tea, breakfast cereals, grain products and pastas, dairy products and dairy product analogs, egg product analogs, fats and oils, meat product analogs, fruit and water ices, batter/breadings, protein and nutritional powders and bars, spices and seasoning mixes, nut products, processed fruits and vegetables, gravies and sauces, condiments, dips, snacks, soups and soup mixes, confections, candies and frostings, jams and jellies, gelatins, puddings, fillings, sweet sauces, toppings and syrups.
Basis: Scientific procedures
Notifier: NapiFeryn BioTech Sp. z o. o.
Notifier Address: ul. Dubois 114/116
93-465 Łódź
Poland
GRAS Notice (releasable information): GRN 1103 in progress for posting
Date of closure: Nov 22, 2023
Date of FDA’s corrected letter: Aug 21, 2024
FDA's Letter: FDA has no questions (in PDF) (462 kB)
Additional correspondence: Aug 15, 2024
Correction Letter (in PDF) (272 kB)
-
-